It has been a big day at Stanford with genomics, not only was the announcement made to better use sequencing to predict own syndrome, but they are also just about ready to receive their new genomic sequencing machine from Helicos. Earlier this year I interviewed Dr. Patrice Milos, Chief Science...
Posted to
The Medical Quack .... by Barbara Duck
on 10-07-2008
Filed under: Medically Related, Technology, Other Items of Interest, My Commentaries, personalized medicine, Genomics, healthcare, Electronic Medical Records, Biotech, cancer research, Research, Gene Sequencing, Disease, Stanford University, DNA Testing, Phamaceuticals, Helicos, Donation
You can set up a log in and donate today. Click here for details. As I had posted in a story a couple days ago, the bar has risen for venture capitalist investments, it is still there, but perhaps a little tougher to get, and with government cuts on grants and availability for research,...
Posted to
The Medical Quack .... by Barbara Duck
on 08-30-2008
Filed under: Medically Related, Other Items of Interest, My Commentaries, healthcare, Biotech, Cancer, Research, Charity, Stand up to Cancer, Donation, Entertainment, Donation Drive, Cancer Cures
Patrice Milos, Vice President and Chief Scientific Officer, Helicos Biosciences This week I had the opportunity to talk with Patrice Milos from Helicos Biosciences who has a long background in global research and spent a number of years at Pfizer as Executive Director at Pfizer Global Research and Development...
Posted to
The Medical Quack .... by Barbara Duck
on 08-15-2008
Filed under: Medically Related, Technology, Pharma/FDA News, Other Items of Interest, My Commentaries, personalized medicine, healthcare, Electronic Medical Records, Biotech, cancer research, Research, Gene Sequencing, Disease, DNA Testing, Phamaceuticals, Helios
It should be the discretion of individual physicians, not insurance companies or pharmacies, to substitute a branded biologic for a biosimilar, which goes back to putting the physician in the decision making process, not the non clinical analyzers. While the search for "cheap" continues...
Posted to
The Medical Quack .... by Barbara Duck
on 08-14-2008
Filed under: Medically Related, Technology, My Commentaries, DNA, Genomics, Biotech, Research, Congress, Pharmaceuticals, Biosimilars
Intellectual Property on the auction block, patents with FDA approval. This is the first time I have noticed technology with health care just up on the open auction block, especially as it relates to cancer research. With the acquisition, it must not fit into the same business model...
At a time like this, thank goodness there are private foundations such as the Hughes Medical Research Institute, as the funding for universities such as Stanford, University of California, Scripps, etc. appears to be in question and citizens all over the US benefit from the research done here in California...
The funds will be given to 56 scientists from more than 2 dozen universities and research institutions. HHMI is the largest private backer of biomedical research in the United States... The Howard Hughes Medical Institute says the $600-million initiative will focus on high-risk, high-reward areas of...